Company Profile

BioCure Inc
Profile last edited on: 12/29/2023      CAGE: 4VUF9      UEI: KM9MB489UNL3

Business Identifier: Medical devices and nanomaterials
Year Founded
2002
First Award
2009
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2975 Gateway Drive Suite 100
Norcross, GA 30071
   (678) 966-3402
   information@biocure.com
   www.biocure.com
Location: Single
Congr. District: 07
County: Gwinnett

Public Profile

BioCure Inc. works in the medical devices and nanomaterials industries. The company's involvement in nanomaterials has expected applications in sensitive analytics and nano filtration. The company's products include: GelSpray™, a novel hydrogel based upon BioCure's proprietary poly(vinyl alcohol) (PVA) technology; polymeric vesicle tec?hnology in the areas of drug delivery and in-vitro diagnostics; a novel in situ polymerizable synthetic nucleus pulposus augmentation hydrogel for the treatment of early degenerative disc disease; and a non-toxic liquid embolic agent providing a clog-free targeted embolization for a range of embolization indications.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 1 NIH $199,889
Project Title: Targeted Multifunctional Polymersomes for Cancer Therapy

Key People / Management

  Andrew Maslaveckas -- President and CEO

Company News

There are no news available.